---
title: "Drug Development Framework"
ocid: "ocds-h6vhtk-028b65"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028b65"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-028b65.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-028b65.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "CARDIFF UNIVERSITY"
published: "2021-01-19"
---

# Drug Development Framework

Buyer: CARDIFF UNIVERSITY  
Current stage: Award  
OCID: ocds-h6vhtk-028b65

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028b65)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-028b65.json)

## Summary

Cardiff University, a leading research institution based in Cardiff, UK, has initiated a tender process for the "Drug Development Framework." This procurement, classified under research laboratory services, is currently in the planning stage, although all associated lots have been cancelled. The university is seeking innovative companies with expertise in drug discovery, specifically those equipped to provide electrophysiology services, in-vivo assays, and drug metabolism services. Potential bidders were required to create an account on In-Tend to access tender documents, which was part of an open procurement method aimed at ensuring transparency and competitiveness.

This tender presents significant opportunities for businesses within the pharmaceutical and biotechnology sectors, especially those that specialise in drug discovery and development. Companies offering research laboratory services, particularly those focused on electrophysiology, in-vivo testing, or drug metabolism studies, would be well-positioned to compete for future contracts. Cardiff University's strong emphasis on innovative solutions and high-quality data presents a chance for suppliers dedicated to enhancing the drug development process, which could be invaluable for companies looking to expand their presence in the health sciences market.

## Notice

Cardiff University are ranked 2nd nationally for the impact of their research and are among the top five universities in the UK for research excellence. Cardiff University has a thriving and innovative research culture, with research that has real impact and makes a positive difference to the world. As part of this, the University is translating fundamental discoveries in disease processes to develop new medicines to meet unmet clinical needs. Cardiff University is looking for companies with an innovative outlook and recognised expertise in supporting drug-discovery projects from early screening (electrophysiology and in vitro DMPK) to delivering de-risked novel molecules to clinical trials. Successful companies will be committed to the principles of the NC3Rs and will add value to our work by providing high-quality data for informing the drug-discovery pipeline.

### Lot Information

Electrophysiology Services

We require providers for electrophysiology services relevant to neuroscience drug development. Currently we require validated ion channel assays for GABAA and NMDA modulators, on an automated electrophysiology platform, with QC and report generation. In the near future, it is likely we will require a range of other ion channel assays, as well as manual patch clamp services. We may also want to purchase ion channel expressing cell lines (under a MTA).

In-vivo assays

We require providers for in-vivo assays, most usually with oral administration. We currently require reliable assays for pro-cognitive and anxiolytic effects. In the future, we may require assays to demonstrate other drug modulated effects, such as, but not limited to, an anti-depressive effect.

In-vitro drug metabolism (ADME-Tox) services

We require providers of in-vitro drug metabolism (ADME-Tox) services as part of our drug development pipeline. This includes, but is not limited to, measures of metabolism, permeability and transporters, physicochemical properties, protein binding and toxicology.

In-vivo pharmacokinetics (PK) and toxicology

We require providers of in-vivo drug metabolism (ADME-Tox) services as part of our drug development pipeline.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/001039-2021 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 19 Jan 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 19 Jan 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Cancelled |
| Lots status | Cancelled |
| Awards status | Unsuccessful |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | CARDIFF UNIVERSITY |
| Additional buyers | EUROPEAN UNION |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF24 0DE |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL52 Cardiff and Vale of Glamorgan |
| Local authority | Cardiff |
| Electoral ward | Adamsdown |
| Westminster constituency | Cardiff East |
| Delivery location | TLL22 Cardiff and Vale of Glamorgan |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73111000 - Research laboratory services

## Release History

- 19 Jan 2021 at 10:24 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/001039-2021

## Notice URLs

- http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers
- https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
- https://ted.europa.eu/udl?uri=TED:NOTICE:177464-2020:TEXT:EN:HTML
- https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0258

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-028b65. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-028b65.json.